Recently, our group identified exportin 1, a nuclear exporter, as a promising therapeutic target in NE tumors, including SCLC and NEPC.226,227 Exportin 1 was found to be upregulated during the very early stages of NE transformation, immediately following TP53 and RB1 inactivation. Here, TP53 is linked to small cell lung carcinoma.